Last €105.80 EUR
Change Today +0.45 / 0.43%
Volume 207.0
PHA On Other Exchanges
Symbol
Exchange
EN Paris
As of 8:55 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

pharmagest interactive (PHA) Snapshot

Open
€106.50
Previous Close
€105.35
Day High
€106.50
Day Low
€105.50
52 Week High
04/8/14 - €117.00
52 Week Low
10/13/14 - €87.16
Market Cap
321.1M
Average Volume 10 Days
589.5
EPS TTM
€5.43
Shares Outstanding
3.0M
EX-Date
07/1/14
P/E TM
19.5x
Dividend
€2.50
Dividend Yield
2.36%
Current Stock Chart for PHARMAGEST INTERACTIVE (PHA)

Related News

No related news articles were found.

pharmagest interactive (PHA) Related Businessweek News

No Related Businessweek News Found

pharmagest interactive (PHA) Details

Pharmagest Interactive Societe Anonyme provides IT solutions for pharmacies in France, Belgium, and Luxembourg. It offers LGPI Global Services software suite, an integrated portal management software that focuses on advice, communication, and pharmacy management; Ma Pharmacie Mobile V2, which provides options in prevention and screening, and personalized advice; and DO-Pill SecuR, a smart electronic pill dispenser, as well as artificial intelligence and expert systems to predict the evolution of patients' health. The company also provides various software packages for pharmacies, including SABCO New, SABCO Optimum, and SABCO Ultimate. In addition, it offers Offisecure, an Internet service provider product; and TELE100T, which provides private health data hosting services on its DATA100T infrastructure platform; SELLEN, a pharmacy robotic system; outsourcing of back-ups for health professionals, pharmacists, and healthcare facilities; and IT solutions for elderly residential care homes and day centers. The company was founded in 1996 and is headquartered in Villers-lès-Nancy, France. Pharmagest Interactive Societe Anonyme is a subsidiary of MARQUE VERTE SANTE.

800 Employees
Last Reported Date: 09/22/14
Founded in 1996

pharmagest interactive (PHA) Top Compensated Officers

Chief Executive Officer, Managing Director, D...
Total Annual Compensation: €202.8K
Founder, Chairman and Member of Finance & Soc...
Total Annual Compensation: €24.0K
Deputy Managing Director, Director of Pharmac...
Total Annual Compensation: €151.9K
Deputy Managing Director, Director of Sales &...
Total Annual Compensation: €117.7K
Compensation as of Fiscal Year 2013.

pharmagest interactive (PHA) Key Developments

Pharmagest Interactive Societe Anonyme Announces Non-Audited Group Sales Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Earnings Guidance for 2014

Pharmagest Interactive Societe Anonyme announced non-audited group sales results for the third quarter and nine months ended September 30, 2014. For the quarter, sales were EUR 27.35 million against EUR 25.45 million a year ago. For the nine months, sales were EUR 85.66 million against EUR 84.59 million a year ago. For the end of 2014, the Group remains confident that its businesses will stay on course with these nine month results, and points out that the development of its overall business suggests an improvement to its profitability level.

Pharmagest Interactive Announces Consolidated Financial Results for Six Months Ended June 30, 2014

Pharmagest Interactive announced consolidated financial results for six months ended June 30, 2014. For the period, the company reported sales of €58.31 million against €59.14 million a year ago. Operating profit was €13.32 million against €11.96 million a year ago. Net profit was €8.68 million against €8.10 million a year ago. Net income - group share was €8.72 million or €2.87 per basic share against €8.05 million or €2.65 per basic share a year ago.

Pharmagest Interactive Societe Anonyme, Board Meeting, Sep 12, 2014

Pharmagest Interactive Societe Anonyme, Board Meeting, Sep 12, 2014. Agenda: To approve earnings results for the six months ended June 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHA:FP €105.80 EUR +0.45

PHA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHA.
View Industry Companies
 

Industry Analysis

PHA

Industry Average

Valuation PHA Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMAGEST INTERACTIVE, please visit www.pharmagest.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.